NxStage Medical Inc.

(NXTM) Trade

By |

Profile

NxStage Medical develops and manufactures products and services for patients with chronic or acute kidney failure. The firm operates in three segments: System One, In-Center, and Services. The System One segment contributes the majority of revenue. It sells and rents the System One portable hemodialysis systems and related consumable products for home and critical care hemodialysis treatments. The In-Center segment sells blood tubing sets and needles for hemodialysis, primarily to dialysis clinics. This business has a high degree of customer concentration. The Services business provides dialysis to customers at NxStage Kidney Care dialysis centers. NxStage generates the majority of its revenue in the United States.

Contact Information

Website: www.nxstage.com
Email: info@nxstage.com
Main Phone: +1 978 687-4700
Address: 350 Merrimack Street
State: MA
City / Town: Lawrence
Country: USA
Postal Code: 1843

Issuer Information

Exchange: NGS
CEO: Jeffrey H. Burbank
Employees: 3800
NAICS: Electromedical and Electrotherapeutic Apparatus Manufacturing(334510)
$ 28.41 $ -0.15 (-0.53%)
Last Price 28.41 Change $ -0.15 Change % -0.53 Tick N/A
Bid 25.85 Bid Size 100.00 Ask 28.72 Ask Size 300.00
Open 28.51 High 28.62 Low 28.27 Prev Close 28.56
Last Trade Volume 1.4 mi 52 Wk Hi 29.26 52 Wk Low 22.70
Market Cap 1.9 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 66,684,692.00 EPS (TTM) -0.08 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 6 62
Number of Buys 5 31
Number of Sells 1 31
Net Activity 56025 -81503
Last 10 Buys Shares
Barry M. Straube 1,000
Earl R. Lewis 1,000
Earl R. Lewis 1,000
Earl R. Lewis 1,000
Robert G. Funari 1,000
Last 10 Sell Shares
Winifred L. Swan 1,000
Winifred L. Swan 1,000
Winifred L. Swan 1,000
Winifred L. Swan 1,000
Matthew W. Towse 1,000
Winifred L. Swan 1,000
Joseph E. Turk 1,000
Winifred L. Swan 1,000
Matthew W. Towse 1,000
Joseph E. Turk 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 32 32 32 32
Low Target Price Estimate 30 30 30 30
Mean Target Price Estimate 30.4 30.4 30.4 30.4
Standard Deviation 0.89 0.89 0.89 0.89
Date of Most Recent Estimate 05/17/18 05/17/18 05/17/18 05/17/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 6 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.71 2.71 2.71 2.71